TGP-580

N/A

Report date: 2024/11/20 10:58:03

Base Information

Drug NameTGP-580
Drug Alias NamebFGF-CS23CS-23TGP-580
ClassificationBiologics
Mechanisms of ActionAngiogenesis inducersFibroblast growth factors modulators
TargetsFibroblast growth factors
Therapy Area/IndicationsPeptic Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPeptic Ulcer

Other Information

ATC CodeN/A
Related LinksN/A